Interim Results from Phase 2a Trial for Nontuberculous Mycobacterial Lung Disease Bring Hope

Nontuberculous mycobacterial (NTM) lung infection occurs when someone inhales nontuberculous mycobacteria from the environment. There are various types of this bacteria, giving NTM different forms. But in all types of NTM, it is this bacteria which sparks the development of the progressive lung disease. NTM can cause fatigue, cough, and weight loss. It frequently becomes a chronic condition. While NTM can be treated with antibiotics, treatment regimes often fail and recurrence is common.

You can read more about this study’s interim results and Molgradex’s potential effects on NTM here.


Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email